NSC697923
NSC697923 Basic information
- Product Name:
- NSC697923
- Synonyms:
-
- Furan, 2-[(4-Methylphenyl)sulfonyl]-5-nitro-
- NSC697923
- 2-[(4-Methylphenyl)sulfonyl]-5-nitrofuran
- 2-Nitro-5-tosylfuran
- 2-Nitro-5-(toluene-4-sulfonyl)-furan
- 2-[(4-Methylphenyl)sulfonyl]-5-nitrofur
- NSC697923 USP/EP/BP
- NSC697923, UBE2N inhibitor
- CAS:
- 343351-67-7
- MF:
- C11H9NO5S
- MW:
- 267.25786
- Product Categories:
-
- Inhibitors
- Mol File:
- 343351-67-7.mol
NSC697923 Chemical Properties
- Melting point:
- 124-126°C
- Boiling point:
- 443.8±40.0 °C(Predicted)
- Density
- 1.416±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Store in freezer, under -20°C
- solubility
- DMSO: soluble20mg/mL, clear
- form
- powder
- color
- white to beige
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 month.
- InChI
- 1S/C11H9NO5S/c1-8-2-4-9(5-3-8)18(15,16)11-7-6-10(17-11)12(13)14/h2-7H,1H3
- InChIKey
- GAUHIPWCDXOLCZ-UHFFFAOYSA-N
- SMILES
- [S](=O)(=O)(c2[o]c(cc2)[N+](=O)[O-])c1ccc(cc1)C
NSC697923 Usage And Synthesis
Description
NSC-69723 (343351-67-7) is a selective inhibitor of the E2 ubiquitin-conjugating enzyme, Ubc13-Uev1A. Does not inhibit UbcH5c activity. Impedes the formation of the Ubc13 and inhibits NF-κB activation in activated B cell-like diffuse large B-cell lymphoma (ABC-DLBCL) cells.1?Blocks proliferation and survival of both ABC-DLBCL and germinal center B cell-like (GCB)-DLBCL cell lines, and survival of primary DLBCL cells. NSC-69723 acts via covalent bonding to E2 active site thiol.2,3?Induces neuroblastoma cell death via activation of p53 and JNK.4
Uses
NSC 697923 is a cell-permeable and selective inhibitor of the ubiquitin-conjugating (E2) enzyme Ubc13-Uev1A and exhibits potent cytotoxicity in a panel of Neuroblastoma (NB) cell lines. NSC 697923 also inhibits the proliferation and survival of diffuse large B-cell lymphoma cells (DLBCL).
in vivo
NSC697923 (5?mg/kg; i.p.; daily for 10 days) suppresses NB tumor growth in SH-SY5Y and NGP xenografts[1].
| Animal Model: | 5- to 6-week-old female athymic Ncr nude mice (orthotopic mouse model of NB; SH-SY5Y and NGP xenografts)[1] |
| Dosage: | 5?mg/kg |
| Administration: | I.p.; daily for 10 days |
| Result: | Significant tumor regression in both SH-SY5Y and NGP xenografts. |
storage
+4°C
Background
NSC-697923 is a small-molecule inhibitor of the E2 ubiquitin-conjugating enzyme Ubc13-Uev1A. NSC-697923 blocked formation of Ubc13 and ubiquitin thioester conjugates, and suppressed constitutive NF-κB activity in diffuse large B cell lymphoma cells. Inhibition of ubiquitin-dependent DNA damage signaling was observed, but not formation of the phosphorylated form of histone variant H2AX, which is consistent with NSC-697923 targeting of nuclear Ubc13. Additional data suggested that NSC-697923 interacted with the Ubc13 active site cysteine. UBE2N is an E2 ubiquitin-conjugating enzyme that catalyzes K63-linked poly-Ub chain formation. UBE2N forms a heterodimer with MMS2 or Uev1A to exert its E2 ligase function. NSC-697923 treatment of neuroblastoma cells increased apoptosis and nuclear p53 accumulation, and enhanced tumor suppression. NSC-697923 also inhibited caspase-1 enzymatic activity and NLRP3 protein expression by suppressing the NF-κB signaling pathway. NSC-697923 inhibited joint swelling and NLRP3 inflammasome activation in an animal model of gouty arthritis.
References
[1] MARY PULVINO. Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A.[J]. Blood, 2012, 120 8: 1668-1677. DOI:10.1182/blood-2012-02-406074
[2] SAM STRICKSON. The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system.[J]. Biochemical Journal, 2013, 451 3: 427-437. DOI:10.1042/bj20121651
[3] CURTIS D. HODGE. Covalent Inhibition of Ubc13 Affects Ubiquitin Signaling and Reveals Active Site Elements Important for Targeting[J]. ACS Chemical Biology, 2015, 10 7: 1718-1728. DOI:10.1021/acschembio.5b00222
[4] J CHENG. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways[J]. Cell Death & Disease, 2014, 5 2: e1079-e1079. DOI:10.1038/cddis.2014.54
NSC697923Supplier
- Tel
- 021-51320588
- tauto@tautobiotech.com
- Tel
- 400-400-164-7117 18317119277
- product02@bidepharm.com
- Tel
- 021-24206007 13764915196
- sales@balmxy.com
- Tel
- 021-52996696,15000506266 15000506266
- Tel
- 021-65675885 18964387627
- info@efebio.com
NSC697923(343351-67-7)Related Product Information
- Motesanib
- YM155 (Sepantronium Bromide)
- Bortezomib
- PYR 41
- Nutlin-3
- Deltarasin
- 2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone
- N-[4-[5-(1,3-BENZODIOXOL-5-YL)-3-METHOXY-1H-1,2,4-TRIAZOL-1-YL]PHENYL]-2-(PHENYLTHIO)ACETAMIDE
- NSC 23766 TETRAHYDROCHLORIDE
- MIF Antagonist, ISO-1
- GSK-3β Inhibitor XVIII
- Pictilisib
- JNJ-10198409
- NSC23005 Sodium
- NSC632839hydrochloride
- KENPAULLONE
- NSC5844
- 3,4-Dichloro-N-(1-Methylbutyl)benza-Mide